北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 基础医学院  > 细胞生物学系  > 期刊论文
学科主题: 基础医学
题名:
Expression of LAPTM4B-35: A novel marker of progression, invasiveness and poor prognosis of extrahepatic cholanglocarcinoma
作者: Zhou, Li1; He, Xiao-Dong1; Cui, Quan-Cai2; Zhou, Wei-Xun2; Qu, Qiang1; Zhou, Rou-Li3; Rui, Jing-An1; Yu, Jian-Chun1
关键词: lysosome-associated protein transmembrane-4 beta ; extrahepatic cholangiocarcinoma ; survival ; resection
刊名: CANCER LETTERS
发表日期: 2008-06-18
DOI: 10.1016/j.canlet.2008.01.025
卷: 264, 期:2, 页:209-217
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Oncology
研究领域[WOS]: Oncology
关键词[WOS]: BILE-DUCT CARCINOMA ; INTRAHEPATIC CHOLANGIOCARCINOMA ; CHOLANGIOCELLULAR CARCINOMA ; HEPATOCELLULAR-CARCINOMA ; SURGICAL-TREATMENT ; OVEREXPRESSION ; SURVIVAL ; RECURRENCE ; EXPERIENCE ; RESECTION
英文摘要:

LAPTM4B was proven to overexpress in hepatocellular carcinoma and relate to differentiation. We immunohistochemically investigated the expression and potential clinicopathological and prognostic significance of LAPTM4B encoded protein, LAPTM4B-35, in extrahepatic cholangiocarcinoma (EHCC) for specimens from consecutive 81 patients. LAPTM4B-35 staining was positive in cancer tissues from 59 patients (72.8%), including 12 with score 1, 22 with score 2 and 25 with score 3. No positive staining was found in non-cancer epithelia. The staining score in cancer tissues was not only significantly associated with TNM staging, histological grade, perineural and lymph node invasion (P < 0.05), but also of comprehensive prognostic implications, including integrated estimation with CA19-9. These data established that LAPTM4B-35 positively expressed in a great portion of EHCC and might be a novel molecular maker of progression, invasiveness and poor prognosis. (C) 2008 Elsevier Ireland Ltd. All rights reserved.

语种: 英语
WOS记录号: WOS:000256776900006
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/51819
Appears in Collections:基础医学院_细胞生物学系_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100032, Peoples R China
2.Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Pathol, Beijing 100032, Peoples R China
3.Peking Univ, Hlth Sci Ctr, Dept Cell Biol, Beijing 100083, Peoples R China

Recommended Citation:
Zhou, Li,He, Xiao-Dong,Cui, Quan-Cai,et al. Expression of LAPTM4B-35: A novel marker of progression, invasiveness and poor prognosis of extrahepatic cholanglocarcinoma[J]. CANCER LETTERS,2008,264(2):209-217.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Zhou, Li]'s Articles
[He, Xiao-Dong]'s Articles
[Cui, Quan-Cai]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Zhou, Li]‘s Articles
[He, Xiao-Dong]‘s Articles
[Cui, Quan-Cai]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace